Overview
Key stats
Fundamentals Sep 9- Open
- $222.83
- 52-wk high
- $243.80
- High
- $224.42
- 52-wk low
- $155.87
- Low
- $221.57
- Prev close
- $223.10
- Mkt cap
- $16.64B
- P/E
- 32.4x
- Volume
- 450.9K
- Fwd P/E
- 23.8x
- Beta
- 0.97
- Div yield
- 1.29%
- P/S
- 4.6x
- P/B
- 4.1x
- Profit margin
- +14.5%
- Op margin
- +22.2%
- ROE
- +13.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 1.4% below what analysts expected.
Earnings per share
$2.10 expected
What the street expects next
EPS expected
$2.21 to $2.27
Revenue expected
10 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $878.7M | $899.1M | $886.9M | $920.6M |
| Cost of what it sold | $488.1M | $512.0M | $488.8M | $493.8M |
| Gross profit | $390.6M | $387.1M | $398.1M | $426.8M |
| What it spent | ||||
| Sales and admin | $204.7M | $201.1M | $218.3M | $224.1M |
| Other operating costs | — | — | $7.4M | $2.8M |
| Total operating expenses | $204.8M | $201.1M | $225.7M | $226.9M |
| What was left | ||||
| Operating profit | $185.8M | $186.0M | $172.4M | $199.9M |
| Interest on debt | $16.5M | $16.2M | $16.0M | $15.1M |
| Profit before tax | $170.5M | $167.7M | $157.0M | $186.1M |
| Tax | $42.8M | $39.4M | $37.1M | $42.7M |
| Net profit | $127.8M | $128.3M | $120.0M | $143.4M |
| EBITDA | $239.1M | $237.4M | $226.7M | $201.2M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
Veeva Systems Director Gordon Ritter Reports Ownership Changes in Form 4 Filing
NeutralSep 4Bayview Legacy LLC Sells 100,000 Shares of Arteris Inc Stock Under Rule 10b5-1 Plan
NeutralSep 3John Wiley & Sons Reports Q1 Fiscal 2027 Earnings in Form 8-K Filing
NeutralSep 3IDEX Corporation Amends and Restates $800 Million Revolving Credit Facility Agreement with Bank of America, JPMorgan Chase Bank, PNC Bank, Wells Fargo Bank, HSBC Bank USA, Mizuho Bank, Bank of China, and Other Lenders
NeutralSep 3IDEX Corp VP Allison S. Lausas Sells 645 Shares for Tax Withholding at $230.28 Each
NeutralSep 2Bill Grogan Appointed Chief Financial Officer at GE HealthCare
NeutralAug 31Avoiding Lag: Real-Time Signals in (IEX) Movement
NeutralAug 29IDEX Corp. stock underperforms Tuesday when compared to competitors
Leans bearishAug 25
Macro
21 macro signals shaping IEX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results